BRAVE Strategy - Breast Cancer Risk Assessment -achieVing Equity

NACompletedINTERVENTIONAL
Enrollment

1,071

Participants

Timeline

Start Date

March 9, 2022

Primary Completion Date

August 30, 2024

Study Completion Date

August 30, 2024

Conditions
Breast Cancer
Interventions
OTHER

Intervention plus 12 months maintenance

The intervention will include 2 months of data collection in the control period, 4 months of education and awareness training, and 12 months of data collection in the maintenance time period.

OTHER

Intervention plus 10 months maintenance

The intervention will include 4 months of data collection in the control period, 4 months of education and awareness training, and 10 months of data collection in the maintenance time period.

OTHER

Intervention plus 8 months maintenance

The intervention will include 6 months of data collection in the control period, 4 months of education and awareness training, and 8 months of data collection in the maintenance time period.

OTHER

Intervention plus 6 months maintenance

The intervention will include 8 months of data collection in the control period, 4 months of education and awareness training, and 6 months of data collection in the maintenance time period.

OTHER

Intervention plus 4 months maintenance

The intervention will include 10 months of data collection in the control period, 4 months of education and awareness training, and 4 months of data collection in the maintenance time period.

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER